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Summary
 
Different T cell subsets exhibit distinct capacities to migrate into peripheral sites of inflamma-
tion, and this may in part reflect differential expression of homing receptors and chemokine re-
ceptors. Using an adoptive transfer approach, we examined the ability of functionally distinct
subsets of T cells to home to a peripheral inflammatory site. The data directly demonstrate the
inability of naive T cells and the ability of effector cells to home to inflamed peritoneum. Fur-
thermore, interleukin (IL)-12 directs the differentiation of either CD4
 
1
 
 or CD8
 
1
 
 T cells into
effector populations that expresses functional E- and P-selectin ligand and that are preferentially
recruited into the inflamed peritoneum compared with T cells differentiated in the presence of
IL-4. Recruitment can be blocked by anti–E- and –P-selectin antibodies. The presence of anti-
gen in the peritoneum promotes local proliferation of recruited T cells, and significantly amplifies
the Th1 polarization of the lymphocytic infiltrate. Preferential recruitment of Th1 cells into the
peritoneum is also seen when cytokine response gene 2 (CRG-2)/interferon 
 
g
 
–inducible protein
10 (IP-10) is used as the sole inflammatory stimulus. We have also found that P-selectin binds
only to antigen-specific T cells in draining lymph nodes after immunization, implying that both
antigen- and cytokine-mediated signals are required for expression of functional selectin-ligand.
Key words: T helper cells type 1 • T helper cells type 2 • lymphocyte homing receptors • 
interleukin 12 • P-selectin
 
A
 
widely accepted model of T lymphocyte recirculation
suggests that naive T cells preferentially migrate from
lymph node to lymph node until they interact with antigen
in the specialized lymph node microenvironment. Antigen
and other signals provided in the lymph node induce dif-
ferentiation of the naive T cells into effector and memory
T cells that leave the lymph node and preferentially migrate
to inflamed tissues (1–4). The distinct migration patterns of
naive and effector/memory T cells is presumably due to dif-
ferential expression of adhesion molecules, called homing re-
ceptors, on naive T cells and effector or memory T cells
(5–8). For example, L-selectin on naive T cells binds to
PNAd on high endothelial venules in lymph nodes and this
molecular interaction mediates, at least in part, the homing
of naive T cells to lymph nodes (9–11). The peripheral re-
cruitment of helper T cells to inflammatory sites is governed
in part by the expression of adhesion molecules on the T
cells that bind to ligands induced on cytokine activated en-
dothelium. Effector and memory T cells express higher levels
of integrins (e.g., CD11aCD18 and CD29dCD49) and CD44
compared with naive T cells (5). In addition, functional se-
lectin ligand expression appears to be absent on naive T cells
and present on effector/memory T cells. For example, we
have previously shown that in humans, CD45RA
 
2
 
RO
 
1
 
memory but not CD45RA
 
1
 
RO
 
2
 
 naive T cells roll effi-
ciently on E- and P-selectin under flow (13). These differ-
ences in the surface phenotypes are likely to contribute to
the preferential recruitment of effector or memory T cells,
but not naive T cells to peripheral sites of inflammation.
Analysis of expression of a number of cell surface markers
indicates that naive T cells are normally absent from sites of
inflammation in mice and humans (2–4). However, there
are few reported studies in which comparative migration of
naive versus activated T cells to inflammatory sites in vivo
have been directly examined.
Naive CD4
 
1
 
 lymphocytes can differentiate into polarized
subsets of effector/helper T cells, characterized by distinct
profiles of cytokine production (14). The exogenous cyto-
kine milieu at the time of initial antigen stimulation is a
major determinant of the pathway of helper T cell differen-
tiation into either Th1 cells, which produce IFN-
 
g
 
, or Th2
cells, which produce IL-4 and IL-5 (14, 15). In addition to
the distinct profiles of cytokine expression, Th1 and Th2
cells may also express distinct sets of surface structures that 
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mediate recruitment patterns to peripheral inflammatory
sites. Recent research has focused on expression of selectin
ligands and chemokine receptor on Th1 and Th2 cells.
Functional ligands for E- and P-selectin appear to be
more highly expressed on Th1 cells than on Th2 cells (16,
17), and this corresponds to an enhanced ability of Th1
cells to enter delayed-type hypersensitivity sites compared
with Th2 cells (16). We and others have recently shown
that IL-12 provides a necessary signal for induction of func-
tional selectin ligands in vitro, and that IL-12 upregulates
 
a
 
3-fucosyltransferase VII, a key enzyme in the production
of the carbohydrate ligands that bind to P- and E-selectin
(18–20). The relative contributions of antigen versus IL-12
signals in inducing functional selectin ligand expression are
not known. Furthermore, the appearance of functional se-
lectin ligand on antigen activated T cells in vivo has not
been described in any detail.
Th1 and Th2 cells also express distinct, but partially
overlapping, sets of chemokine receptors (21). IP-10 is a
CXC chemokine that is produced by endothelial cells and
macrophages stimulated by IFN-
 
g
 
 (23). IP-10 induces
rapid and transient adhesion of human IL-2–stimulated
T lymphocytes to endothelial cells through its receptor
CXCR3, which is selectively expressed on activated T cells
(24, 25). In addition, CXCR3 is more abundantly ex-
pressed on human Th1 cells than on Th2 cells, and as a re-
sult IP-10 selectively attracts Th1 cells in in vitro migration
assays (26–28). CRG-2 has been identified to be the mu-
rine homologue of IP-10 (29). However, the effect of
CRG-2 on differentiated murine Th1 and Th2 cells is not
known.
Subsets of CD8
 
1
 
 cytolytic T lymphocytes (CTLs)
 
1
 
 have
been defined on the basis of the cytokines they produce
(30–33). CTLs that predominantly secrete IFN-
 
g
 
 and IL-2
are called Tc1 cells, by analogy to Th1 cells, whereas CTLs
that predominantly secrete IL-4, IL-5, and IL-10 are called
Tc2 cells. Recent studies have indicated that Tc1 and Tc2
cells have stable phenotypes in vivo after adoptive transfer
(34), and that these subsets may have different patterns of
migration into inflammatory sites (35). The possibility that
Tc1 and Tc2 cells differ in expression of functional selectin
ligands has not been explored.
In the studies presented here, we have examined the dif-
ferential recruitment of mouse T cell subsets to a peripheral
inflammatory site. We have used adoptive transfer of naive
or differentiated TCR transgenic CD4
 
1
 
 T cells into nor-
mal mice, and adoptive transfer of fluorescently labeled,
 
Staphylococcus
 
 enterotoxin B (SEB)–stimulated CD4
 
1
 
 and
CD8
 
1
 
 T cells. Our results directly demonstrate differences
in recruitment capabilities among both CD4
 
1
 
 and CD8
 
1
 
 T
cell subsets, and the importance of functional selectin ligand
expression and chemokines in selective recruitment. Fur-
thermore, we have exploited the DO11 TCR transgenic
adoptive transfer model to examine the effect of antigen on
both the induction of T cell selectin ligands in vivo and on
the accumulation of Th1 cells at an inflammatory site.
 
Materials and Methods
 
Mice.
 
BALB/c mice, 4–6 wk of age, were purchased from
The Jackson Laboratory. Transgenic mice expressing the
DO11.10 TCR (DO11) (36), specific for the chicken OVA pep-
tide OVA
 
323–339
 
 in the context of the MHC class II molecule
I-A
 
d
 
, were obtained from Dr. D. Loh (Hoffmann-LaRoche,
Nutley, NJ). The DO11 mice were bred in our pathogen and vi-
ral antibody–free facility in accordance with guidelines of the
Committee on Animals of the Harvard Medical School, and
those prepared by the Committee on Care and Use of Laboratory
Animals of the Institute of Laboratory Resources, National Re-
search Council (Washington, D.C.). The mice were typed for
the DO11 TCR by staining peripheral blood cells with antibod-
ies against CD4 and V
 
b
 
8 as previously described (37).
 
Reagents.
 
Murine IL-4 was obtained from the culture super-
natant of the I3XL6 cell line (obtained from Dr. Abul Abbas,
Brigham and Women’s Hospital), which constitutively expresses
a stably transfected murine IL-4 gene. Recombinant murine
IL-12 was a gift of Dr. Stan Wolf (Genetics Institute, Cambridge,
MA). IL-2–containing supernatants were obtained from the X63-
IL2 cell line, which expresses a stably transfected murine IL-2
gene (obtained from Dr. Fritz Melchers, Basel Institute of Immu-
nology, Basel, Switzerland). The hybridoma cell line producing
anti–IL-4 (clone 11B11) was obtained from the American Type
Culture Collection. Neutralizing anti–mouse IFN-
 
g
 
 (XMG1.2)
was purchased from PharMingen. Human E- and P-selectin hu-
man IgG chimeric proteins (38, 39) were provided by Dr. R.
Camphausen (Genetics Institute). OVA
 
323–339
 
 was produced by
the peptide synthesis facility of the Center for Neurologic Dis-
eases, Brigham and Women’s Hospital. Murine recombinant IP-
10/CRG-2 was obtained from R&D Systems.
 
Purification and In Vitro Differentiation of T Cells.
 
Naive
 
 
 
CD4
 
1
 
T cells were purified from pooled lymph nodes and spleen cells
from DO11 mice by using CD4
 
1
 
 Dynalbeads and Detach-a-bead
reagent (Dynal A.S., Norway) according to the manufacturer’s
instructions. More than 95% of the cells were CD4
 
1
 
 as assessed
by flow cytometry using FITC-conjugated anti–mouse CD4
 
1
 
mAbs. The CD4
 
2
 
 fraction of the DO11 spleen and lymph node
suspensions, or whole spleen cell suspensions from BALB/c mice,
were treated with mitomycin C for 30 min at 37
 
8
 
C and used as
APCs for DO11 T cells. T cell differentiation was induced by
culturing 2 
 
3
 
 10
 
5
 
 purified CD4
 
1
 
 TCR transgenic T cells in 1 ml
of RPMI 1640 with 10% FCS with 2 
 
3
 
 10
 
6
 
 APCs, 1 
 
m
 
M
OVA
 
323–339
 
,
 
 
 
and Th0 condition (no cytokines), Th1 condition
(10 ng/ml IL-12 plus anti–IL-4 [11B11 hybridoma supernatant,
25% vol/vol]), or Th2 condition (1,000 U/ml IL-4 plus anti–
IFN-
 
g
 
 [XMG 1.2, 1 
 
m
 
g/ml]). The cultures were fed with fresh
medium containing 10 U/ml IL-2 after 4 d, and harvested for
adoptive transfer on day 6.
In some experiments, suspensions of BALB/c mouse lymph
node and spleen cells were differentiated in vitro by stimulation
with 2 
 
m
 
g/ml SEB (Sigma Chemical Co.) in the presence of cyto-
kine and antibody reagents used for Th1 and Th2 differentiation, as
described above. 6 d later, cells were harvested, centrifuged over
Ficoll-sodium metrizoate (Cappel), labeled with a fluorescent
tracker dye (see below), and used in adoptive transfer studies.
 
Adoptive Transfers and Immunization.
 
Freshly prepared suspen-
sions of whole lymph node and spleen cells from DO11 mice
 
1
 
Abbreviations used in this paper:
 
 CMFDA, 5-chloromethylfluorescein diac-
etate; CTL, cytolytic T lymphocyte; SEB, Staphylococcus enterotoxin B. 
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were used as a source of naive cells for adoptive transfer, as previ-
ously described (37). In vitro differentiated DO11 T cells were
harvested at day 6 and centrifuged over Ficoll-sodium metrizoate
before adoptive transfer. The number of T lymphocytes express-
ing the DO11 TCR in each population was measured by flow
cytometric analysis of cell suspensions stained with the clonotypic
antibody, KJ1-26 (40, 41) (see below). Naive or differentiated T
cells (1.5–2.0 
 
3
 
 10
 
7
 
 in 500 
 
m
 
l PBS) were adoptively transferred
into unirradiated BALB/c recipients by tail vein injection. 6 h
later, mice were given intraperitoneal injections of 500 
 
m
 
g OVA
protein or PBS emulsified in IFA (Difco) or with IP-10/CRG-2
in PBS. 5, 48, or 72 h after adoptive transfer, spleen and lymph
nodes (inguinal, axillary, and mesenteric) were removed and
peritoneal cells were harvested by PBS lavage. Cell suspensions
were prepared and analyzed by flow cytometry for surface anti-
gen expression.
In some experiments, mice received naive DO11 T cells by
tail vein injection, and were immunized 24 h later with OVA (100
 
m
 
g) emulsified in CFA (Difco) through footpad injection. Drain-
ing popliteal and inguinal lymph nodes were harvested at varying
times after immunization, and cell suspensions were prepared and
were analyzed by flow cytometry.
SEB-stimulated T cell cultures were harvested at day 6, centri-
fuged over Ficoll-sodium metrizoate, and then incubated with 1 
 
m
 
M
Cell Tracker Green (5-chloromethylfluorescein diacetate [CM-
FDA]; Molecular Probe) diluted in RPMI 1640 with 10% FBS
for 20 min at 37
 
8
 
C. Cells were centrifuged and incubated for an
additional 30 min at 37
 
8
 
C in fresh medium to allow elution of
unreacted dye before transfer. Labeled cells (1.5–2.0 
 
3
 
 10
 
7
 
) were
then adoptively transferred into BALB/c mice through tail vein
injection. 6 h later, mice were given intraperitoneal injections of
500 
 
m
 
l of PBS-IFA. 72 h after transfer, spleen, lymph nodes, and
peritoneal cells were harvested and analyzed by flow cytometry.
 
FACS
 
®
 
 Analysis.
 
In DO11 adoptive transfer studies, sus-
pensions of cells from peritoneum, lymph node, or spleen were
first incubated with 5 
 
m
 
g/ml anti-CD16/CD32 (PharMingen) to
block Fc receptors. The cells were then stained with 1 
 
m
 
g/ml
PE-labeled anti-CD4 antibody (PharMingen), and 1 
 
m
 
g/ml bio-
tinylated KJ1-26 clonotypic antibody followed by Cy-Chrome–
streptavidin (PharMingen), as previously described (37). These
cells were also stained with 1 
 
m
 
g/ml P-selectin–human IgG chi-
mera (38, 39), followed by FITC-conjugated anti–human IgG
(Southern Biotechnology Associates). SEB-stimulated T cells
were stained with 1 
 
m
 
g/ml biotinylated anti-V
 
b
 
8 antibody (Phar-
Mingen) followed by Cy-Chrome–streptavidin (PharMingen).
SEB-stimulated cells were also stained with 1 
 
m
 
g/ml PE-labeled
anti-CD8 or anti-CD4 antibodies (PharMingen), as well as with
soluble P-selectin–IgG and FITC-conjugated anti-IgG, as de-
scribed above for DO11 cells. More than 95%
 
 
 
of the
 
 
 
CD4
 
2 
 
V
 
b
 
8
 
1
 
T cells in the SEB-stimulated populations were CD8
 
1
 
. We
therefore chose to analyze CD4
 
1
 
V
 
b
 
8
 
1
 
 and CD4
 
2
 
V
 
b
 
8
 
1
 
 T cells in
the same staining tubes as a convenient way to compare CD4
 
1
 
and CD8
 
1
 
 populations while still being able to use two additional
fluorochromes for V
 
b
 
8 and P-selectin ligand analysis. All analyses
were performed on a FACScan
 
®
 
 flow cytometer (Becton Dickin-
son). In some studies, CMFDA (green tracker dye)-labeled T
cells were detected by direct fluorescence in the FL1 channel on
the flow cytometer.
 
Results
 
Naive versus Effector T Cell Recruitment to Inflammatory
Sites.
 
We have recently shown that, in contrast to anti-
gen-stimulated DO11 T cells, naive DO11 T cells fail to
roll on selectins under flow conditions in vitro, nor do they
bind soluble P- or E-selectin Ig chimeric molecules (18).
To determine whether naive T cells are capable of entering
a peripheral inflammatory site, we directly transferred
spleen and lymph node cells from normal DO11 mice into
BALB/c recipients and then further challenged the mice
intraperitoneally with IFA. After 3 d, the recipient mice
were assayed for the number of adoptively transferred cells
in the peritoneum as well as in peripheral lymph node and
spleen. As has been previously reported, naive DO11 T
cells homed to lymph nodes, and to a lesser extent to spleen
(Fig. 1 A). In contrast, DO11 CD4
 
1
 
 T cells were not de-
tectable (
 
,
 
0.2%) in the peritoneum of either the control or
IFA-treated mice (Fig. 1 A). The numbers of DO11 CD4
 
1
 
T cells in both spleen and lymph nodes were comparable in
control and IFA-treated mice, indicating that roughly equal
number of cells were adoptively transferred into the circu-
lation of each mouse.
The T cells we isolated from normal DO11 mice express
Figure 1. Recruitment of naive versus effector CD41 T cells to inflamed peritoneum. 1.5 3 107 naive CD41KJ1261 T cells (A) or 1.8 3 107 in vitro–
activated CD41 T cells (B) were adoptively transferred into BALB/c mice. After 6–24 h, mice were either left untreated (control) or were given intra-
peritoneal injections of IFA. 3 d later, spleens, lymph nodes, and peritoneal cells were collected and stained with PE-conjugated anti-CD4 and Cy-Chrome–
labeled KJ126. The numbers adjacent to the upper right corner of each panel are the percentage of the total gated cells that are CD41KJ1261 cells. One
of two comparable experiments is shown. 
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high levels of L-selectin and low levels of CD25 and
CD44, which is a typical phenotype for naive T cells (Fig.
2). After 6 d in culture with APCs and OVA peptide (see
Material and Methods, Th0 condition), DO11 T cells had
acquired a typical activated phenotype: L-selectin
 
low
 
CD25
 
high
 
CD44
 
high
 
 (Fig. 2). Upon restimulation with OVA peptide,
these activated CD4
 
1
 
 T cells produced both IFN-
 
g
 
 and
IL-4, as assayed by ELISA (data not shown). After they
were transferred into BALB/c mice, the activated DO11
CD4
 
1
 
 T cells were recruited to the IFA-treated perito-
neum (Fig. 1 B). The frequency of CD4
 
1
 
KJ126
 
1
 
 cells in
the peritoneum increased from 0.9 
 
6 
 
0.1% to 3.4 
 
6 
 
0.3%
(
 
n
 
 5 
 
2 experiments) in the absence and presence of IFA,
respectively. In contrast, the frequency of CD4
 
1
 
KJ126
 
1
 
cells in the spleens remained comparable at 4.1 
 
6 
 
0.4% and
3.9 
 
6 
 
0.3% (
 
n
 
 5 
 
2 experiments) in the control and IFA-
treated mice, respectively. Thus, we conclude that al-
though both activated and naive CD41 T cells are capable
of entering secondary lymphoid tissues, only the activated
subset is recruited to the inflamed peritoneum.
Recruitment of Th1 versus Th2 CD41 Cells to a Site of In-
flammation. To compare the recruitment of Th1 versus
Th2 cells to an inflammatory site, we first generated differ-
entiated Th1 and Th2 populations of DO11 T cells in vitro
as described in Materials and Methods. Th1 cells produced
abundant IFN-g but no IL-4, whereas Th2 cells produced
abundant IL-4 but little IFN-g, as judged by cytokine
ELISA assay and intracellular cytokine staining (reference
18 and data not shown).
DO11 Th1 or Th2 cells were adoptively transferred into
syngeneic BALB/c recipient mice, the mice were chal-
lenged with intraperitoneal injection of IFA and the num-
ber of adoptively transferred CD41KJ1261 cells in spleen,
lymph nodes or peritoneum was determined 3 d later. Re-
sults of a typical experiment are shown in Fig. 3. In that ex-
periment, adoptively transferred Th1 cells comprised 3.1%
of total peritoneal cells, whereas adoptively transferred Th2
cells comprised only 0.7%. In contrast, Th1 and Th2 cell
recruitment into spleen or lymph nodes was approximately
equal. In four experiments, the frequency of adoptively
transferred Th1 cells in IFA-treated peritoneum was 3.2 6
1.0 times the frequency of adoptively transferred Th2 cells.
When OVA and IFA were injected into the peritoneum,
and cells were recovered 3 d later, the percentage of
DO11 T cells was significantly enhanced compared with
exudates from animals treated with IFA alone. Further-
more, there was a greater difference between the numbers
of Th1 and Th2 cells in the peritoneum when OVA was
present than when it was absent (Fig. 4). In the experiment
shown, adoptively transferred Th1 cells comprised 19% of
the total peritoneal cells in the IFA plus OVA-treated peri-
toneum, whereas Th2 cells comprised only 3.1%. The ab-
solute numbers of DO11 T cells recruited in the perito-
neum at various time points during this experiment are
shown in Table I. With IFA alone at day 3, 106 DO11 Th1
cells were recruited to the peritoneum, which was five
times more than the number of DO11 Th2 cells recruited
under identical conditions. In the presence of IFA plus
OVA, 3.2 3 106 of DO11 Th1 cells were present in peri-
toneum at day 3, but only 4 3 105 DO11 Th2 cells were
recruited under identical conditions. The increased number
of Th1 cells in the peritoneum when OVA is present may
be due to increased recruitment and/or local proliferation
Figure 2. Phenotype of naive and activated T cells. Naive cells repre-
sented in this figure were CD41 T cells freshly isolated from DO11 mice,
and activated cells represent DO11 T cells stimulated in vitro with OVA
peptide and APCs, as described in Materials and Methods. The histograms
depict staining for the indicated molecule using PE-labeled secondary an-
tibody after gating on CD41 (FITC) plus KJ1261 (Cy-Chrome) cells.
One of two comparable experiments is shown.
Figure 3. In vivo recruitment of
Th1 versus Th2 cells to adjuvant-
treated peritoneum. DO11 Th1 or
Th2 cells (2 3 107) were adoptively
transferred into BALB/c mice. Af-
ter 24 h, mice were given intraperi-
toneal injections of PBS-IFA. 3 d
later, lymph nodes (inguinal, axillary,
and mesenteric), spleen, and peri-
toneal cells were collected and stained
with PE-conjugated anti-CD4 and
Cy-Chrome–labeled KJ126. The
numbers adjacent to the upper right
corner of each panel are the percent-
age of the total gated cells that are
CD41KJ1261 cells. One of four
comparable experiments is shown.1769 Xie et al.
in response to antigen after recruitment. When DO11 Th1
cells were labeled with tracker dye before transfer, the day
3 recovered peritoneal cells from OVA plus IFA treated
mice had significantly less tracker dye than cells recovered
from IFA-treated mice (Fig. 5). The loss of tracker dye cor-
relates with cell division and dilution of the intracellular la-
bel among progeny cells (37, 42-44). This indicates local
proliferation accounts for at least some of the accumulation
of Th1 cells when antigen is present.
To determine if the cytokine secretory phenotype of the
adoptively transferred Th1 and Th2 cells remained stable in
vivo, the recovered peritoneal cells were stimulated with
OVA peptide and culture supernatants were assayed for
IFN-g and IL-4 production. Consistent with previous
findings (45), DO11 Th1 and Th2 cells maintain their ef-
fector cytokine profile in vivo (data not shown).
Role of Selectin Ligand Expression in T Cell Subset–specific
Recruitment. To dissect the mechanisms for differential re-
cruitment of T cell subsets into the inflamed peritoneum,
we first examined the role of P- and E-selectins and their
ligands on T lymphocytes. T cells constitutively express
PSGL-1, the best described receptor for P-selectin, which
becomes functional only after posttranslational modification
(46, 47). The P-selectin binding status of T cells was exam-
ined by FACS® analysis using soluble P-selectin–human
IgG fusion protein. As shown in Fig. 6 A, naive CD41 T
cells failed to bind P-selectin. After in vitro differentiation
with peptide and specific cytokines, Th1 cells bound much
more P-selectin than Th2 cells did. To further investigate
whether binding to P- and E-selectin is essential for the se-
lective recruitment of CD41 T cells to the inflamed perito-
neum, we studied the migration of Th1 cells under the in-
fluence of antibodies against P- and E-selectin. As shown in
Fig. 6 B, combination of antibodies against P- and E-selec-
tin effectively blocked Th1 cells from entering IFA-treated
peritoneum. The percentage of DO11 T cells in the peri-
toneum dropped from 7 to 1.6%, whereas the number of
DO11 T cells in spleens remained comparable in these
two groups of mice. This data indicates that the interaction
of P- and E-selectin with their ligands is essential for maxi-
mal recruitment of Th1 cells into sites of inflammation.
IP-10/CRG-2 Induced Preferential Recruitment of Th1 Cells
to a Peripheral Site. Chemokines activate integrins on leu-
kocytes and trigger firm interaction of leukocytes to endo-
thelium (48–50). Recently, human CXCR3, receptor for
IP-10, was shown to be highly expressed in Th1 but not in
Th2 cells (26–28). To demonstrate a possible role of
chemokines in mediating selective recruitment of T cell
subsets in vivo, we injected the mouse IP-10 homologue,
CRG-2, into the peritoneum of mice after adoptive trans-
fer of either DO11 Th1 or Th2 cells. In response to CRG-2
treatment, DO11 Th1 cells were recruited to the perito-
neum more efficiently than Th2 cells. In the experiment
Figure 4. Influence of antigen on recruitment of Th1 versus Th2 cells
to peritoneum. DO11 Th1 or Th2 cells (2 3 107) were adoptively trans-
ferred into BALB/c mice. After 24 h, mice were given intraperitoneal in-
jections of either OVA-IFA or PBS-IFA. 3 d later, spleen and peritoneal
cells were collected and stained with PE-conjugated anti-CD4 and Cy-
Chrome–labeled KJ126. The numbers adjacent to the upper right corner
of each panel are the percentage of the total gated cells that are
CD41KJ1261 cells. One of four comparable experiments is shown.
Figure 5. Antigen-induced pro-
liferation of adoptively trans-
ferred Th1 cells in response to
antigen in peritoneum. DO11
Th1 cells (2 3 107) were la-
beled with green tracker (CM-
FDA) before adoptive transfer
into BALB/c mice. Recipient
mice were given intraperitoneal
injections of either OVA-IFA
(OVA1) or PBS-IFA (OVA2),
and 3 d later peritoneal cells
were harvested and stained with
PE-conjugated anti-CD4 and Cy-Chrome–labeled KJ126. The green
tracker visualized in FL-1 shown here is gated on CD41KJ1261 cells.
Table I. In Vivo Recruitment of Th1 versus Th2 Cells to 
Adjuvant-treated Peritoneum
Time after
adoptive
transfer 
Th1 Th2
OVA-IFA PBS-IFA OVA-IFA PBS-IFA
h
5 1.1 3 104 0.9 3 104 3 3 103 2 3 103
48 8.3 3 104 ND ND ND
72 3.2 3 106 106 4 3 105 2 3 105
DO11 Th1 or Th2 cells (2 3 107) were adoptively transferred into
BALB/c mice. After 24 h, mice were given intraperitoneal injections of
either OVA-IFA or PBS-IFA. 3 d later, peritoneal cells were collected
after 5, 48, or 72 h and stained with PE-conjugated anti-CD4 and Cy-
Chrome–labeled KJ126. The cell numbers presented here are numbers
of DO11 CD41KJ1261 cells in the peritoneum according to percent-
age of CD41KJ1261 cells and total number of peritoneal cells. One of
two comparable experiments is shown.1770 T Cell Recruitment In Vivo
shown in Fig. 7, Th1 cells comprised 7.9% of the total
peritoneal population in CRG-2 treated mice, whereas
Th2 cells comprised 2.3% in similarly treated mice. The to-
tal numbers of Th1 and Th2 cells harvested from the
CRG-2–treated mice were 2.5 3 105 and 4 3 104 respec-
tively. In two experiments in which CRG-2 treatment was
performed, the frequency of adoptively transferred Th1
cells in the peritoneum was 3.7 6 0.4 times the frequency
of adoptively transferred Th2 cells. Therefore, differential
expression of chemokine receptors and functional P/E-selec-
tin ligand(s) contribute to differences in recruitment of T
cell subsets.
Recruitment of IL-12 versus IL-4 –stimulated CD81 T Cells
to a Site of Inflammation. In vitro stimulation of BALB/c
spleen cells with SEB for 6 d gave rise to activated CD41
and CD81 T cells. Over 80% of this mixed population was
Vb81 (data not shown) and CD81 T cells comprised from
50 to 66% of the Vb81 cells. Under the influence of Th1
promoting cytokines (IL-12 plus anti–IL-4), a majority of
CD41Vb81 and CD81Vb81 T cells bound P-selectin (Fig.
8 A). The ratio of CD41/CD81 cells propagated under
these condition was z1:2. On the other hand, under the
influence of Th2 promoting cytokines (IL-4 plus anti–
IFN-g), both CD41Vb81 and CD81Vb81 populations
failed to bind P-selectin (Fig. 8 A). The CD41/CD81 ratio
of the cells propagated under these conditions was 1:1.
To demonstrate in vivo recruitment of CD41 and CD81
SEB-stimulated T cells, the cells were labeled with green
tracker dye (CMFDA) before adoptive transfer. As pre-
dicted based on P-selectin binding status shown above, a
selective recruitment was clearly observed. After 3 d of IFA
treatment, IL-12–treated cells were recruited to perito-
neum more efficiently than those IL-4–treated cells. As
shown in Fig. 8 B, IL-12–treated cells represented 16% of
total peritoneal population, whereas IL-4–treated cells only
represented 1.5%. In four experiments, the frequency of
adoptively transferred cells in the peritoneum that were
originally differentiated under Th1 conditions was 6.5 6
2.8 times greater than the frequency of adoptively trans-
ferred cells originally differentiated under Th2 conditions.
Furthermore, the CD41/CD81 ratio of the Vb81 cells re-
covered from the peritoneum was always the same as in the
initial adoptively transferred population (data not shown).
This indicates that conditions that promote CD41 Th1 dif-
ferentiation also act on CD81 T cells to induce functional
selectin ligands and the ability to migrate into inflammatory
sites.
Induction of T Cell P-selectin Ligand Expression In Vivo.
We have demonstrated that naive T cells stimulated with
antigen and IL-12 in vitro differentiate into P-selectin
binding cells that are capable of entering an inflammatory
site. To determine if naive T cells upregulate functional
P-selectin ligand in response to antigen in vivo, we adop-
tively transferred naive DO11 T cells into BALB/c recipi-
ent mice. After 24 h, the mice were immunized by footpad
injection with OVA peptide and CFA to provide specific
Figure 6. P- and E-selectin–mediated recruitment of Th1 cells into an inflammatory site. (A) Naive, Th1, or Th2 cells were stained with P-selectin Ig
chimeric protein (Psel-IgG) or with human Ig control (HuIgG) followed by FITC-conjugated anti–human-Ig. Cells were also stained for CD4 (PE) and
KJ126 (Cy-Chrome). The histogram shown represents cells gated on the CD41KJ1261 population. One of three comparable experiments is shown. (B)
Isotype control rabbit IgG or anti–P- and E-selectin antibodies were injected via tail vein together with Th1 cells into BALB/c mice. After 24 h, PBS-
IFA was injected into the peritoneum of these mice. 3 d later, spleen and peritoneal cells were collected and stained with PE-conjugated anti-CD4 and
Cy-Chrome–labeled KJ126. The numbers adjacent to the upper right corner of each panel are the percentage of the total gated cells that are
CD41KJ1261 cells. One of two comparable experiments is shown.
Figure 7. IP-10/CRG-2–mediated preferential recruitment of T
helper cells in vivo. DO11 Th1 and Th2 cells were adoptively transferred
into BALB/c mice through tail vein injection. After 24 h, mice either
were left untreated or else received an intraperitoneal injection of 0.5 mg
of CRG-2. 3 d later, spleen and peritoneal cells were collected and
stained with PE-conjugated anti-CD4 and Cy-Chrome–labeled KJ126.
The numbers adjacent to the upper right corner of each panel are the per-
centage of the total gated cells that are CD41KJ1261 cells.1771 Xie et al.
antigen as well as a stimulus for IL-12 production. Draining
lymph nodes were removed after 1, 2, and 3 d and cells
were stained for CD4, DO11 TCR (KJ126), and P-selectin
binding. As shown in Fig. 9 A, the DO11 CD41KJ1261 T
cells expanded in lymph nodes in response to OVA stimu-
lation. The percentage of CD41KJ1261 T cells increased
from 3.1% to 8.7% by day 2 and further increased to 13%
by day 3. At day 2 after immunization, there was a signifi-
cant increase in the number of CD41KJ1261 cells that
bound P-selectin (Fig. 9 B). Interestingly, there was no in-
crease in P-selectin binding by the CD41KJ1262 popula-
tion indicating that cytokines in the lymph node cannot in-
duce P-selectin ligand expression on T cells not directly
stimulated by antigen. Forward scatter analysis indicated
that the P-selectin binding cells were the largest, presum-
ably most activated cells among the CD41KJ1261 popula-
tion (data not shown).
Discussion
In this study, we examined recruitment of different sub-
sets of T lymphocytes into a peripheral inflammatory site.
Using the adoptive transfer approach, we were able to fol-
low specific populations of cells with distinct phenotypic
characteristics. The peritoneal inflammatory model was
chosen because recruitment of T cells can be easily quanti-
fied by flow cytometric analysis of cells harvested from the
cavity, the recruitment process requires transmigration across
an endothelial barrier, and different inflammatory stimuli
can be administered by intraperitoneal injections. The in-
jection of IFA into the peritoneum induces a mixed in-
Figure 8. The P-selectin binding and peritoneal recruitment of SEB-stimulated BALB/c splenic CD41 and CD81 T cells. (A) Spleen cells were stim-
ulated in vitro with 2 mg/ml of SEB with either IL-12 plus anti–IL-4 antibody or with IL-4 plus anti–IFN-g antibody. After 6 d of culture, cells were
harvested and stained for CD4, Vb8, and P-selectin Ig (Psel-IgG) or control human Ig (HuIgG) as described in previous figures. (B) The same cell popu-
lations as described in A were labeled with green tracker dye before tail vein injection into BALB/c mice. After 24 h, mice were injected in the perito-
neum with PBS-IFA. 3 d later, spleen and peritoneal cells were collected and visualized by flow cytometry. The numbers in the plots represent the per-
centage of total gated cells that are tracker dye positive (CMFDA). One of four comparable experiments is shown.
Figure 9. Induction of functional P-selectin ligand expression on antigen-activated T cells in vivo. Naive (1.5 3 107) CD41KJ1261 T cells were adop-
tively transferred into BALB/c mice. After 24 h, mice were either left untreated or further immunized with OVA and CFA by footpad injection. Drain-
ing lymph nodes were collected at days 1, 2, and 3, and were stained with PE-conjugated anti-CD4 and Cy-Chrome–labeled KJ126 and with P-selectin
Ig chimeric protein (Psel-IgG) or with human Ig control (HuIgG) followed by anti–human Ig conjugated with FITC. The number of DO11 T cells in
the draining lymph nodes is shown in A. The numbers adjacent to the upper right corner of each panel are the percentage of the total gated cells that
are CD41KJ1261 cells. P-selectin binding by CD41KJ1261 or CD41KJ1262 populations is shown in B.1772 T Cell Recruitment In Vivo
flammatory infiltrate that changes over time, but includes
activated neutrophils and lymphocytes at day 3 (data not
shown).
Although there are many studies supporting the hypoth-
esis that effector and naive T cells have different migratory
patterns in vivo (3, 4, 51), there is little data directly com-
paring the abilities of effector and naive T cells to enter T
peripheral inflammatory sites. The adoptive transfer of TCR
transgenic T cells is a powerful method with which to ad-
dress homing patterns of T cells. It has been used exten-
sively to study homing of antigen specific T cells to sec-
ondary lymphoid tissues (52), but this technique has been
applied only in a limited way to the study of effector T cell
homing to inflammatory sites (35, 53). Our finding that na-
ive DO11 T cells fail to enter the IFA-treated peritoneum,
whereas activated effector DO11 T cells do, provides im-
portant direct evidence for the concept that effector T cells
preferentially home to peripheral inflammatory sites but
naive T cells do not.
We have also found that Th1 cells are more efficiently
recruited to the inflamed peritoneum than are Th2 cells.
This is consistent with previous studies indicating that Th1
cells enter dermal delayed-type hypersensitivity sites to a
greater degree than Th2 cells (16). In our experiments,
both Th1 and Th2 cells migrated to spleen and lymph node
in equivalent numbers. This indicates that Th2 cells were as
efficiently transferred into the circulation as Th1 cells, and
that there is no intrinsic defect in the ability of in vitro–
generated Th2 populations to transmigrate out of blood
vessels into tissues. Furthermore, others have shown that
Th2 cells can also migrate into lung tissue in mouse models
of allergic airway inflammation (16, 54). On the other hand,
in a murine model of autoimmune gastritis, activated Th2
cells are found in draining lymph nodes but not gastric mu-
cosa, whereas Th1 cells are abundant in the mucosa (55).
Thus, Th2 cells appear to be capable of entering only a sub-
set of inflammatory sites. Differential recruitment of Th1 but
not Th2 cells into inflammatory sites has been attributed to
the expression of higher levels of functional selectin ligands
on Th1 cells than Th2 cells (16–18, 20, 56). Consistent with
those studies, we have found that the adoptively transferred
Th1 cells express more P-selectin ligand than do the Th2
cells, and that anti–P- plus anti–E-selectin antibodies dimin-
ish Th1 recruitment into the peritoneum (Fig. 6 B). Unlike
previous reports, we have examined the effect of the pres-
ence of antigen on the relative accumulation of antigen-spe-
cific Th1 and Th2 cells at the site. We have found that the
difference between Th1 and Th2 cell accumulation seen
without antigen is amplified when antigen is present (see Fig.
4 and Table I). The tracker-dye data indicate that the in-
creased number of Th1 cells in the peritoneum in the pres-
ence of antigen is at least partially attributable to local prolif-
eration. Thus the combination of preferential recruitment
and then antigen-induced expansion of recruited cells ap-
pears to markedly polarize the phenotype of the helper T cell
responses to peripheral antigen.
It is not clear if there are adhesion molecules that medi-
ate selective recruitment of Th2 cells into inflammatory
sites, such as in the asthmatic lung. A possible candidate is
very late activation antigen (VLA)-4 on T cells interacting
with vascular cell adhesion molecule (VCAM)-1 on in-
flamed endothelium. We have shown previously that an
active form of VLA-4 that is capable of binding to VCAM-1
under physiological shear stress is expressed on memory but
not naive human helper T cells (13). In addition, the Th2
cytokine, IL-4, can induce VCAM-1 expression on endo-
thelial cells (57–59).
The expression of functional P-selectin ligand on CD41
(13, 47, 56, 60) and CD81 (61) T cells has been described. An
important finding in this study is that the conditions used
to drive CD41 Th1 differentiation in vitro, namely anti-
gen, IL-12, and anti–IL-4, also induce functional P-selectin
ligand expression on CD81 cells, whereas Th2 differentia-
tion conditions, namely antigen, IL-4, and anti–IFN-g
generate CD81 T cells that do not bind P-selectin. Fur-
thermore, P-selectin ligand expression on CD81 T cells
correlates with their ability to home to the inflamed perito-
neum. It is not clear whether the effector functions of these
two CD81 populations are different or not, although Tc1
and Tc2 subsets of CD81 T cells producing different cyto-
kines have been described (31, 34, 62). Recent evidence
does suggest that adoptively transferred influenza-specific
Tc1 cells are better able to clear pulmonary influenza infec-
tion then are Tc2 cells, even though both populations have
comparable cytolytic activity (35). This may reflect differ-
ent recruitment kinetics between the two populations or the
effects of the different cytokines they produce. Our data
suggest that the microenvironmental conditions in which
naive CD81 T cells are differentiated into CTLs are likely
to influence not only the effector functions of these cells, but
also their selectin-dependent homing patterns to peripheral
inflammatory sites, just as with CD41 helper T cells.
The data showing induction of P-selectin ligand on
lymph node T cells in vivo indicate one mechanism by
which recruitment of effector T cells at inflammatory sites
can be biased toward antigen-specific cells. We have shown
that functional P-selectin ligand is induced on antigen-speci-
fic naive T cells in lymph nodes draining a site of exposure
to the antigen, but not on bystander T cells that cannot
recognize the antigen but are otherwise exposed to the
same local cytokine milieu. Induction of P-selectin ligand
on lymph node T cells has been reported recently, but that
study did not use TCR-transgenic T cells and the antigen
specificity of the ligand induction could not be addressed
(1). The in vivo activated CD41 DO11 T cells described in
this paper appear to be Th1-type as they produce abundant
IFN-g but no IL-4 upon restimulation with OVA peptide.
Because survival and propagation of naive TCR transgenic
T cells in vitro requires antigen stimulation, it has not been
possible to distinguish the necessity of T cell receptor sig-
nals from cytokine signals for the induction of functional
selectin ligands. In the in vivo study reported here, viable T
cells that cannot bind the administered antigen fail to ac-
quire the ability to bind P-selectin, even though the mi-
croenvironment includes the necessary cytokines.
Although the acquisition of a selectin binding pheno-1773 Xie et al.
type appears to distinguish effector T cell subsets and deter-
mines their capability of homing to peripheral inflamma-
tory sites, the induction of other functional adhesion
molecules on T cells during effector differentiation are also
likely to be important in peripheral homing. For example,
CD44–dependent hyaluronate binding increases specifi-
cally on Vb81 lymph node T cells in SEB-treated mice,
and these hyaluronate-binding T cells are selectively re-
cruited to SEB-containing peritoneum in a CD44-depen-
dent manner (63). It is possible that CD44 or other adhe-
sion molecules may also contribute selective recruitment of
effector T cell subsets.
In summary, the results presented here support the fol-
lowing model. When naive T cells encounter antigen in
the lymph node, they become activated, undergo clonal
expansion, and they differentiate into one or another subset
of effector cells depending on the local cytokine milieu.
During this process of activation and differentiation, spe-
cific adhesion molecules, including functional selectin ligands,
and chemokine receptors are induced on the surface of ac-
tivated T cells, in subset-specific patterns. Therefore, after
entering circulation, the T cells are capable of migrating to
particular peripheral sites where appropriate adhesion mol-
ecules and chemokines (ligands to the receptors on the T
cells) are expressed or displayed by endothelium. The re-
quirement that both antigen and cytokine signals be pro-
vided in the draining lymph nodes in order to stimulate the
expression of functional selectin ligands may contribute to
relative enrichment antigen–specific T cells at peripheral
inflammatory sites. Maintenance of a functionally polarized
T cell response at a peripheral site appears to require sub-
set-specific recruitment, but the polarization is amplified by
antigen-driven proliferation of the recruited T cells.
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